Platelet transfusion and tranexamic acid to prevent bleeding in outpatients with a hematological disease: A Dutch nationwide survey

por Cornelissen, Loes L., Caram‐Deelder, Camila, Meier, Romy T., Zwaginga, Jaap Jan, Evers, Dorothea
Publicado 2020

Risk factors for bleeding in haemato-oncology patients—a nested case–control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained)

por Cornelissen, Loes L, Caram-Deelder, Camila, van der Bom, Johanna G, Middelburg, Rutger A, Zwaginga, Jaap Jan
Publicado 2020

Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro

por van Bladel, Esther R, de Jager, Rosa L, Walter, Daisy, Cornelissen, Loes, Gaillard, Carlo A, Boven, Leonie A, Roest, Mark, Fijnheer, Rob
Publicado 2012

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks

por Cornelissen, Loes L., Caram‐Deelder, Camila, Fustolo‐Gunnink, Susanna F., Groenwold, Rolf H. H., Stanworth, Simon J., Zwaginga, Jaap Jan, van der Bom, Johanna G.
Publicado 2021

Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study

por Cornelissen, Loes L., Kreuger, Aukje L., Caram-Deelder, Camila, Middelburg, Rutger A., Kerkhoffs, Jean Louis H., von dem Borne, Peter A., Beckers, Erik A. M., de Vooght, Karen M. K., Kuball, Jürgen, Zwaginga, J. J., van der Bom, Johanna G.
Publicado 2020